Cargando…

Involving patients in treatment decisions, disease management and research for end-stage kidney disease

Detalles Bibliográficos
Autores principales:	Jager, Kitty J, van der Veer, Sabine N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497372/ https://www.ncbi.nlm.nih.gov/pubmed/37711633 http://dx.doi.org/10.1093/ckj/sfad171

Ejemplares similares

The role of kidney registries in expediting large-scale collection of patient-reported outcome measures for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2021)

European nephrologists’ views on remote patient management for end-stage kidney disease
por: de Jong, Rianne W, et al.
Publicado: (2021)

RICORS2040: the need for collaborative research in chronic kidney disease
por: Ortiz, Alberto
Publicado: (2021)

Pulmonary hypertension in the changing landscape of congenital heart disease: Global differences and a possible driver of end-stage heart failure
por: Van De Bruaene, A., et al.
Publicado: (2016)

Gaps and challenges in the provision of treatment for patients with end-stage renal disease: perspectives from the Philippines
por: Pajimna, Janine Audrei T., et al.
Publicado: (2023)

Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF)
por: Tizard, E. Jane, et al.
Publicado: (2009)

A new methodological series in CKJ: from basic-level methodology to artificial intelligence in medicine
por: Zoccali, Carmine, et al.
Publicado: (2023)

Probiotics for kidney disease
por: Favero, Chiara, et al.
Publicado: (2022)

Editorial comment on Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence – The role of Vitamin K in managing chronic kidney disease–mineral bone disorder
por: Hou, Yi-Chou, et al.
Publicado: (2022)

Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease
por: Torra, Roser, et al.
Publicado: (2021)

European East–West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomes
por: Carriazo, Sol, et al.
Publicado: (2020)

Diagnosis 101: diabetic kidney disease
por: Lerma, Edgar V
Publicado: (2022)

Chronic kidney disease and end-stage renal disease—a review produced to contribute to the report ‘the status of health in the European union: towards a healthier Europe’
por: Zoccali, Carmine, et al.
Publicado: (2010)

Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
por: Watanabe, Hiroshi, et al.
Publicado: (2018)

The importance of psychiatric disorders in end-stage kidney disease patients
por: Lee, Eun
Publicado: (2022)

More on the invisibility of chronic kidney disease… and counting
por: Carriazo, Sol, et al.
Publicado: (2021)

Thiazides in chronic kidney disease: “back to the future”
por: de la Espriella, Rafael, et al.
Publicado: (2022)

Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference
por: Levey, Andrew S, et al.
Publicado: (2020)

Evidence of chronic kidney injury in patients not meeting KDIGO criteria for chronic kidney disease
por: Alvarez-Llamas, Gloria, et al.
Publicado: (2022)

Deprivation and kidney disease—a predictor of poor outcomes
por: Guthrie, Greg D, et al.
Publicado: (2019)

To improve the life of patients with kidney disease: the impact of exercise
por: Clyne, Naomi, et al.
Publicado: (2021)

Living well with kidney disease by patient and care partner empowerment: kidney health for everyone everywhere
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2021)

Optimizing the timing of nephrology referral for patients with diabetic kidney disease
por: Martínez-Castelao, Alberto, et al.
Publicado: (2020)

Results of the European EDITH nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease
por: de Jong, Rianne W, et al.
Publicado: (2021)

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020)

Megalin/lipoprotein receptor-related protein 2 autoimmunity and kidney disease
por: Perez-Gomez, Maria V, et al.
Publicado: (2020)

Digital health interventions in chronic kidney disease: levelling the playing field?
por: Graham-Brown, Matthew P M, et al.
Publicado: (2022)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Long COVID and kidney disease
por: Yende, Sachin, et al.
Publicado: (2021)

Male baldness; association with coronary artery disease?
por: van der Wall, E.E.
Publicado: (2015)

Committing to implementation research for health systems to manage and control non-communicable diseases
por: Marten, Robert, et al.
Publicado: (2021)

Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease
por: Mathew, Roy O, et al.
Publicado: (2016)

Age-old musings: twenty-first century management of advanced kidney disease in older individuals
por: Jassal, Sarbjit Vanita, et al.
Publicado: (2021)

Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone
por: Mao, Zhiguo, et al.
Publicado: (2021)

Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?
por: Copur, Sidar, et al.
Publicado: (2022)

Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”
por: de la Espriella, Rafael, et al.
Publicado: (2023)

Erratum to: Results of the European EDITH Nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease
por: de Jong, Rianne W, et al.
Publicado: (2021)

The Netherlands as frontrunner of collaborative research in adult congenital heart disease
por: Robbers-Visser, D., et al.
Publicado: (2016)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34gq633tqrsuh0sddtqr6r0p76